These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22474698)

  • 1. AWP leaves, AAC arrives; can it really do the job?
    Carroll J
    Manag Care; 2012 Mar; 21(3):6-7. PubMed ID: 22474698
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
    Latham SR
    J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
    [No Abstract]   [Full Text] [Related]  

  • 3. AWP reimbursement scrutinized by several states.
    Carroll J
    Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 5. The Department of Health and Human Services. Medicaid pharmacy management strategy--2003-2005.
    Odom CH; Wade T
    N C Med J; 2003; 64(6):278-9. PubMed ID: 14983616
    [No Abstract]   [Full Text] [Related]  

  • 6. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 7. Marketing Medicaid drugs: an analysis of cost factors.
    Simmons SA; Payne BC; Smith MC
    J Health Care Mark; 1986 Sep; 6(3):29-36. PubMed ID: 10301037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism?
    Gencarelli DM
    NHPF Issue Brief; 2002 Jun; (775):1-19. PubMed ID: 12083159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicaid drug system, AWP policies are 'broken'.
    Med Health; 2005 Jul; 59(23):4. PubMed ID: 16104107
    [No Abstract]   [Full Text] [Related]  

  • 10. Principal findings from the Washington State cognitive services demonstration project.
    Christensen DB; Holmes G; Fassett WE; Neil N; Andrilla CH; Smith DH; Andrews A; Bell EJ; Hansen R; Shafer R; Stergachis A
    Manag Care Interface; 1998 Jul; 11(7):60-2, 64. PubMed ID: 10181572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of nursing home reimbursement.
    Deane RT
    Health Care Strateg Manage; 1985 Aug; 3(8):26-8. PubMed ID: 10300315
    [No Abstract]   [Full Text] [Related]  

  • 12. Policy implications of MAC: AWP-AAC differentials among pharmacies.
    Norwood GJ; Lipson DP; Freeman RA
    J Am Pharm Assoc; 1977 Aug; 17(8):496-9. PubMed ID: 893916
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managed care payments, drug prices ripe for savings efforts.
    Med Health; 2005 Oct; 59(37):2, 7. PubMed ID: 16250202
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicaid data-analysis for long term care groups.
    Bishop DW
    J Am Health Care Assoc; 1982 Sep; 8(5):45-8. PubMed ID: 10298661
    [No Abstract]   [Full Text] [Related]  

  • 16. Watching the reimbursement dollars: program validation aims to control waste.
    Nicholson DE
    Group Pract J; 1981 Jan; 30(1):11-3, 25. PubMed ID: 10298067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of prepayment on Medicaid drug costs.
    Yesalls CE; Norwood GJ; Lipson DP
    Contemp Pharm Pract; 1979; 2(2):87-94. PubMed ID: 10297462
    [No Abstract]   [Full Text] [Related]  

  • 18. Is your reimbursement system fair?
    Deane RT
    J Am Health Care Assoc; 1985 Dec; 11(8):39-43. PubMed ID: 10300488
    [No Abstract]   [Full Text] [Related]  

  • 19. States' options for reimbursing nursing home capital.
    Spitz B
    Inquiry; 1982; 19(3):246-56. PubMed ID: 6215350
    [No Abstract]   [Full Text] [Related]  

  • 20. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
    Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.